http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101203954-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101203954-B1 |
| titleOfInvention | Immune modulating composition comprising vascular endothelial mesenchymal stem cells |
| abstract | The present invention relates to a composition for immunomodulatory and pancreatic islet cell transplantation comprising vascular endothelial mesenchymal stem cells. More specifically, cells having vascular endothelial cell properties differentiated from bone marrow-derived mesenchymal stem cells are excellent in the ability to generate blood vessels and inhibit immunity, and particularly diseases of the pancreatic islets that can be prevented or treated by inhibiting immune responses. It can be useful when transplanting. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103524236-A |
| priorityDate | 2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 359.